Seventeen differential metabolites were identified, including cellobiose, chenodeoxycholic acid 3-sulfate, D-alanine, D-alanyl-d-alanine, glycoursodeoxycholic acid 3-sulfate, diaminopimelic acid, D-glutamic acid, deoxyglycocholate, phenylpyruvic acid, urobilinogen, L-homoserine, N2-succinyl-ornithine, hydroxypropionic acid, indoleacetic acid, taurodeoxycholic acid, N-methylnicotinamide, and glycocholic acid (Table S2)
B, Exudates
The global burden of polyneuropathyIn need of an accurate assessment
We would appreciate feedback on potentially adopting patient safety related eCQMs which are currently used in the Hospital Inpatient Quality Reporting (IQR) Program, including: Hospital HarmOpioid-Related Adverse Events eCQM, Hospital Harm-Severe Hypoglycemia eCQM, and Hospital Harm-Severe Hyperglycemia eCQM